A Review of Precice Intramedullary Limb Lengthening (IMLL) System for Limb Lengthening Procedures in Children.
Palo Alto (17 mi)Age: < 18
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: N/A
Waitlist Available
Sponsor: NuVasive
No Placebo Group
Trial Summary
What is the purpose of this trial?This study will look at how safe and effective limb lengthening surgeries are for the femur and tibia in children 12 years old and younger. We will examine any complications from the surgery, the results of X-rays, and feedback from patients. The study will involve the Precice Intramedullary Limb Lengthening (IMLL) System and external fixator devices for limb lengthening.
Eligibility Criteria
Treatment Details
2Treatment groups
Experimental Treatment
Group I: Precice IMLL SystemExperimental Treatment1 Intervention
Patients 12 years of age or younger received Precice IMLL for correction of limb length discrepancy.
Group II: External FixatorExperimental Treatment1 Intervention
Patients 12 years of age or younger received an external fixator for correction of limb length discrepancy.
Find a clinic near you
Research locations nearbySelect from list below to view details:
Paley InstituteWest Palm Beach, FL
Loading ...
Who is running the clinical trial?
NuVasiveLead Sponsor